Literature DB >> 17693188

Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population.

Jianfeng Shao1, Min Gu, Zhuoqun Xu, Qiang Hu, Lixin Qian.   

Abstract

The incidence rate for bladder cancer has been increasing in many countries, and bladder cancer is the most common urinary cancer in China. We explored the association of single-nucleotide polymorphisms in DNA repair genes with bladder cancer. The hypothesis is that the xeroderma pigmentosum complementary group D (XPD) 156-22541C-->A and 751-35931A-->C polymorphisms are associated with the risk of bladder cancer. In a population-based case-control study, 215 patients with newly diagnosed bladder transitional cell carcinoma and 245 cancer-free controls/healthy subjects (frequency-matched by the age and sex) were genotyped. These two polymorphisms were studied using the polymerase chain reaction restriction fragment length polymorphism method. We found that the A allele of XPD Arg156Arg (C22541A) and the C allele of XPD Lys751Gln (A35931C) is associated with increased risk of bladder cancer (adjusted odds ratio = 1.54 and 95% confidence interval = 1.19-2.01, 1.65, and 1.12-2.73, respectively). Smoking is also a risk factor in the etiology of bladder cancer, but alcohol intake is a protective factor during the development of bladder cancer. These two XPD polymorphisms may play an important role in the etiology of bladder cancer in the southeastern Chinese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693188     DOI: 10.1016/j.cancergencyto.2007.05.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Authors:  Yuanyi Wu; Yong Yang
Journal:  Tumour Biol       Date:  2014-02-07

2.  The association between the Lys751Gln polymorphism in the XPD gene and the risk of bladder cancer.

Authors:  Tianyuan Xiong; Jiqiao Yang; Haichuan Wang; Fanyi Wu; Yang Liu; Rui Xu; Zi Lv; Pei Xue; Wen Cao; Yonggang Zhang
Journal:  Mol Biol Rep       Date:  2014-02-18       Impact factor: 2.316

3.  XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.

Authors:  Chunxiang Li; Zheng Jiang; Xinghan Liu
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

Review 4.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

5.  Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.

Authors:  Sheng Li; Xian Tao Zeng; Xiao Lan Ruan; Tong Zu Liu; Xing Huan Wang
Journal:  Mol Biol Rep       Date:  2014-02-08       Impact factor: 2.316

6.  Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide.

Authors:  Ruchika Gangwar; Parmeet Kaur Manchanda; Rama Devi Mittal
Journal:  Genetica       Date:  2008-10-23       Impact factor: 1.082

7.  Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.

Authors:  Su-Xia Li; Qiang-Sheng Dai; Su-Xiu Chen; Shao-Dan Zhang; Xiao-Yu Liao; Xia Deng; Hong-Bo Chi; Feng-Jie Li; Jin-Hong Zhu; Yi-Yan Jiang
Journal:  Tumour Biol       Date:  2013-12-18

8.  Susceptibility of XPD and hOGG1 genetic variants to prostate cancer.

Authors:  Cheng Zhou; Li-Ping Xie; Yi-Wei Lin; Kai Yang; Qi-Qi Mao; Yue Cheng
Journal:  Biomed Rep       Date:  2013-05-30

9.  XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.

Authors:  Xi Dai Long; Yun Ma; Yun Feng Zhou; Jin Guang Yao; Fu Zhi Ban; Yong Zhi Huang; Bing Cheng Huang
Journal:  BMC Cancer       Date:  2009-11-17       Impact factor: 4.430

10.  ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.

Authors:  Xiaobo Lu; Yanhua Liu; Tao Yu; Sha Xiao; Xiaoyan Bao; Liang Pan; Guolian Zhu; Yuan Cai; Qiufang Liu; Cuihong Jin; Jinghua Yang; Shengwen Wu; Li An; Tahar van der Straaten
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.